Resources · Case Studies
What pharma teams do when the work stops fighting them
Anonymized results from commercial, medical affairs, and market access teams running pharcel on their own data, indications, and field forces.
Across every engagement
8 weeks
average saved per planning cycle
4x
more verified experts surfaced
23%
average lift in territory equity
99.2%
HCP verification precision
Selected results
Read how teams put pharcel to work
Commercial
Top-10 Global Pharma
8 weeks
saved per territory planning cycle
Annual alignment ran through spreadsheets and consultants, leaving plans stale before they reached the field.
Read case studyMedical Affairs
Mid-size Specialty Oncology
4x
more verified KOLs identified
Manual KOL mapping missed emerging investigators and could not scale across new tumor types.
Read case studyMarket Access
Rare Disease Biotech
60%
faster payer dossier assembly
Evidence for value dossiers lived across disconnected teams with no single source of truth.
Read case studyCommercial
Regional Cardiovascular Franchise
23%
lift in territory equity after first optimization
Uneven workload across reps meant high-potential accounts were consistently under-covered.
Read case studyMedical Affairs
Global Immunology Leader
12,000+
HCPs verified with evidence in one indication
Existing databases were riddled with duplicates and unverifiable profiles no MSL could trust.
Read case studyMarket Access
Mid-size Neurology Specialist
3x
faster real-world evidence synthesis
Literature and trial evidence for HEOR reviews was gathered by hand, delaying submissions.
Read case studyYour data, your indication, your results
Book a demo and we will run pharcel live on your own market so you can see the outcome before you commit.
Request a Demo